Metzger D W, Furman A, Miller A, Sercarz E E
J Exp Med. 1981 Sep 1;154(3):701-12. doi: 10.1084/jem.154.3.701.
A panel of hybridoma antibodies obtained from lymphoid cells that were fused during a primary response ("early") or a secondary response ("late") gave results concordant with analysis of conventional, in vivo-produced anti-lysozyme idiotypes: early antibodies did not display the predominant anti-hen eggwhite lysozyme idiotype (IdX-HEL), whereas late antibodies all displayed IdX-HEL. Furthermore, individual late hybridomas could each remove the entire anti-IdX-HEL activity by absorption, whereas early hybridomas could not. The epitope specificities of the hybridomas in both the early and late populations were heterogenous. We conclude that epitypic specificity in the response to HEL is determined independently from idiotypic specificity and that the predominant idiotype is selected for during the maturation of the anti-lysozyme response.
一组从在初次应答(“早期”)或二次应答(“晚期”)中融合的淋巴细胞获得的杂交瘤抗体,其结果与对传统的体内产生的抗溶菌酶独特型的分析一致:早期抗体不显示主要的抗鸡卵清溶菌酶独特型(IdX-HEL),而晚期抗体均显示IdX-HEL。此外,单个晚期杂交瘤可通过吸收去除全部抗IdX-HEL活性,而早期杂交瘤则不能。早期和晚期群体中的杂交瘤的表位特异性是异质的。我们得出结论,对HEL应答中的表位特异性是独立于独特型特异性而确定的,并且主要独特型是在抗溶菌酶应答成熟过程中被选择的。